Evidence map›Paper›PMID 33222397›Full record

ArticleActa physiologica (Oxford, England)2021

Germ-free mice are not protected against diet-induced obesity and metabolic dysfunction.

Chiara H Moretti, Tomas A Schiffer, Xuechen Li, Eddie Weitzberg, Mattias Carlström, Jon O Lundberg

Open access · hybridAbstract read
In one paragraph

Article in Acta physiologica (Oxford, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. TheMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Questioning the foundations of the gut microbiota and obesity.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  10. Article
  11. Microbiota-dependent and -independent effects of obesity on transplant rejection and hyperglycemia.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Gut physiology meets microbiome science.Gut microbiome (Cambridge, England) · 2023
    Review
  16. Gut Microbiota Restores Central Neuropeptide Deficits in Germ-Free Mice.International journal of molecular sciences · 2022
    Article
  17. Article
  18. Article
  19. iScience · 2022
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Chiara H MorettiDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-0434-0278
Tomas A SchifferDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Xuechen LiDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Eddie WeitzbergDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Mattias CarlströmDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-9923-8729
Jon O LundbergDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Karolinska Institutet · SEChinese Academy of Medical Sciences & Peking Union Medical College · CNKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimStudies in the past 15 years have highlighted the role of the gut microbiota in modulation of host metabolism. The observation that germ-free (GF) mice are leaner than conventionally raised (CONV) mice and their apparent resistance to diet-induced obesity (DIO), sparked the interest in dissecting the possible causative role of the gut microbiota in obesity and metabolic diseases. However, discordant results among studies leave such relationship elusive. In this study, we compared the effects of chronic Western diet (WD) intake on body weight and metabolic function of GF and CONV mice.

methodsWe fed GF and CONV mice a WD for 16 weeks and monitored body weight weekly. At the end of the dietary challenge, the metabolic phenotype of the animals was assessed. Muscle carnitine palmitoyltransferase I (CPT1) and liver AMPK activation were investigated.

resultsBoth GF and CONV mice gained weight and developed glucose intolerance when fed a WD. Moreover, WD feeding was associated with increased adipose tissue inflammation, repressed hepatic AMPK activity, fatty liver and elevated hepatic triglycerides in both groups of mice. Enhanced fatty acid oxidation in the GF mouse is one of the proposed mechanisms for their resistance to DIO. The GF mice in this study showed higher CPT1 activity as compared to their CONV counterparts, despite not being protected from obesity.

conclusionsWe provide evidence that the microbiota is not an indispensable factor in the onset of obesity and metabolic dysfunction, suggesting that the relationship between gut bacteria and metabolic diseases needs further exploration.

Indexed as

Gastrointestinal MicrobiomeMicrobiotaAnimalsDiet, High-FatDiet, WesternLiverMiceMice, Inbred C57BLObesitydiabetesdietgerm-free micemetabolic syndromemicrobiotaobesity

Identifiers

PMID33222397
PMCPMC7988602
OpenAlexW3109877677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.